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Introduction
Juvenile Dermatomyositis (JDM) is an inflammatory
myopathy with a predilection for proximal muscles and
skin. Current treatment of JDM includes early aggressive
use of corticosteroids coupled with immunosuppressive
drugs such as methotrexate, cyclosporine and intrave-
nous immune globulins (IVIG). Delay to diagnosis and
inadequate treatment increase the risk of developing cal-
cinosis. However, once estabilished, this complication is
difficult to treat.
Objectives
We describe a case of JDM with severe skin manifesta-
tions including ulcerations and diffuse calcinosis, poorly
responsive to conventional therapy.
Methods
Case report. A caucasian boy presented at the age of 3
years and 10 months with malaise, fatigue, arthralgia,
heliotrope rash, Gottron’s papules on PIP joints, elbows
and knees, shawl sign, and periungueal telangectasia.
There was weakness of proximal muscles, elevation of
aldolase (11.0 U/L, normal < 7.3 U/L), normal serum
lactate dehydrogenase (LDH) and creatine kinase (CK),
and negative anti-nuclear antibody. Magnetic resonance
imaging (MRI) demonstrated diffuse muscle edema of
proximal muscles and electromyography showed a myo-
pathic pattern. Despite treatment with steroids pulses,
followed by daily oral steroids and hydroxycloroquine,
his illness was complicated by skin ulcerations of the
upper and lower extremities and widespread calcinosis.
X-ray of extremities showed superficial diffuse nodules
and plaques. The patient still had elevation of aldolase
(19.3 U/L) and a Childhood Myositis Assessment
Scale (CMAS) score of 35 out of 52, with a Manual Mus-
cle Testing (MMT8) score of 50 out 80. So a treatment
with Methotrexate was added, but his areas of calcinosis
and ulcerations continued to spread, so alendronate was
introduced (two years from disease onset), but without
benefit. On the basis of a published report (Arabshahi B,
et al. J Pediatr 2012) treatment with topical sodium thio-
sulfate was initiated. Thiosulphate was used initially at
3% concentration, and subsequently increased to 10%
concentration, applied to calcification of upper and lower
extremities daily under occlusive dressing.
Results
After 9 months of therapy, a significant improvement of
calcinosis and ulcerations was noted, together with lack
of progression. Photos, with the family consent, were
taken before and after treatment.
Conclusion
Treatment of calcinosis in JDM is very difficult. Several
agents have been used, such as calcium channel blockers,
probenecid, colchicine, tumor necrosis factors inhibitors,
bisphosphonates, and intra-lesional corticosteroids. None
of these however has shown to be consistently effective
and no controlled trial exist. Sodium thiosulfate is a
potent antioxidant and vasodilator that also chelates and
dissolves calcium deposits. Topical use has been
described for ulcerations associated with lupus calcinosis
and uremic calciphylaxis. However, the use of this agent
for treatment of calcinosis associated to dermatomyositis
has been reported only once in literature.
We hypothesize that sodium thiosulfate may have
a role in stabilizing or improving calcinosis, and in
1AOU Meyer-Rheumatology Department, Florence, Italy
Full list of author information is available at the end of the article
Pagnini et al. Pediatric Rheumatology 2013, 11(Suppl 2):P26
http://www.ped-rheum.com/content/11/S2/P26
© 2013 Pagnini et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
diminishing pain and promoting revascularization of
cutaneous ulcerations. A controlled study in order to
determinate the safety and efficacy of this treatment in
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